Table 2.

Final Restricted and Full eRADAR Model Coefficients for Predicting Undiagnosed Dementia

Predictor	Restricted Model	Full Model
Intercept	−11.83	−11.86
Demographics
Age (per year)	0.11	0.11
Female	−0.10	−0.07
Diagnoses, past 2 years
Congestive heart failure	0.28	0.23
Cerebrovascular disease	0.18	0.16
Diabetes, any	0.06
Diabetes, complex	0.34	0.29
Chronic pulmonary disease	−0.11	−0.10
Hypothyroidism	0.05	0.02
Renal failure	−0.15	−0.13
Lymphoma	0.01
Solid tumor without metastases	−0.17	−0.16
Rheumatoid arthritis	−0.05	−0.01
Weight loss	−0.34	−0.31
Fluid and electrolyte disorders	−0.07	−0.06
Blood loss anemia	−0.25	−0.22
Psychoses	0.46	0.43
Depression	0.03
Traumatic brain injury	0.20	0.17
Tobacco use disorder	−0.15	−0.12
Atrial fibrillation	0.03	0.02
Gait abnormality	0.24	0.20
Vital signs, most recent, past 3 years
Underweight (BMI < 18.5)	0.29	0.26
Obese (BMI ≥ 30)	−0.11	−0.09
High blood pressure (≥140 SBP or ≥90 DBP)	−0.09	−0.07
Healthcare utilization, past 2 years
≥1 outpatient visit	−0.55	−0.53
≥1 emergency department visit	0.34	0.30
≥1 home health visit	0.00
≥1 physical therapy visit	−0.13	−0.14
≥1 speech, language and learning visit	0.47	0.42
Medications, past 2 years
Fill for non-tricyclic antidepressant	0.58	0.55
Fill for sedative-hypnotic	0.03
Additional predictors considered for full model
≥1 clinic “no show”		0.18
≥1 ACS hospitalizations		0.10
≥1 ACS emergency visits		−0.06
Medication non-adherencea		0.29

Values reflect truncated coefficients from the final restricted and full models. Full coefficients are included in Supplementary Table S2. ACS, ambulatory care sensitive; BMI, body mass index; DBP, diastolic blood pressure; SBP, systolic blood pressure.

^adefined as <80% of days covered (PDC) for oral anti-diabetics, anti-hypertensives or statins